Clinical Outcomes of Definitive Chemoradiotherapy for Cervical Esophageal Cancer
Yutaro Tasaki(Nagasaki University Hospital), Kazuto Ashizawa(Nagasaki University), Mika Nakatake(Japanese Red Cross Society, Japan), Koichi Honda(Yamagata University), Asuka Takahira(Japanese Red Cross Society, Japan), Tatsuya Takeda(Nagasaki Medical Center), Daisuke Nakamura(The University of Osaka), Shuhei Miyazaki(Nagasaki University Hospital), Akiko Egawa(The Jikei University Hospital), Takuya Yamazaki(Sasebo City General Hospital)
Cited by 4
Related Papers
Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis
|Hepatology|2006|365
Natural History of Pulmonary Subsolid Nodules: A Prospective Multicenter Study
|Journal of Thoracic Oncology|2016|273
Genome-wide Association Study Identifies TNFSF15 and POU2AF1 as Susceptibility Loci for Primary Biliary Cirrhosis in the Japanese Population
|The American Journal of Human Genetics|2012|272
Clonal analysis of the epithelial component of W0arthin's tumor
|Human Pathology|2000|65